Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-21 · accession 0001213900-24-016026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-21 | INM | HULL ANDREW | Dir | P - Purchase | $0.39 | +37.5K | 38.3K | +4,947% | +$14.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | P | A | 37,500 | $0.39 | 38,258 | D | — | — |